ISRG - Intuitive Surgical Stock Price, News & Analysis

$396.59 -1.90 (-0.48 %)
(As of 11/24/2017 03:45 AM ET)
Previous Close$398.49
Today's Range$394.68 - $398.49
52-Week Range$203.57 - $400.00
Volume488,800 shs
Average Volume684,412 shs
Market Capitalization$44.44 billion
P/E Ratio52.48
Dividend YieldN/A
Beta0.47

About Intuitive Surgical (NASDAQ:ISRG)

Intuitive Surgical logoIntuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company's instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.


Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:ISRG
CUSIP46120E60

Debt

Debt-to-Equity RatioN/A
Current Ratio4.76%
Quick Ratio4.39%

Price-To-Earnings

Trailing P/E Ratio52.48
Forward P/E Ratio50.52
P/E Growth5.51

Sales & Book Value

Annual Sales$2.70 billion
Price / Sales16.43
Cash Flow$7.60 per share
Price / Cash52.17
Book Value$44.27 per share
Price / Book8.96

Dividend

Annual DividendN/A
Dividend YieldN/A

Profitability

Trailing EPS$7.74
Net Income$735.90 million
Net Margins30.16%
Return on Equity18.20%
Return on Assets15.90%

Miscellaneous

Employees3,755
Outstanding Shares112,050,000

Frequently Asked Questions for Intuitive Surgical (NASDAQ:ISRG)

What is Intuitive Surgical's stock symbol?

Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."

When did Intuitive Surgical's stock split? How did Intuitive Surgical's stock split work?

Intuitive Surgical shares split before market open on Friday, October 6th 2017. The 3-1 split was announced on Friday, August 11th 2017. The newly minted shares were payable to shareholders after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of Intuitive Surgical stock prior to the split would have 300 shares after the split.

How were Intuitive Surgical's earnings last quarter?

Intuitive Surgical, Inc. (NASDAQ:ISRG) released its quarterly earnings data on Thursday, October, 19th. The medical equipment provider reported $2.77 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.99 by $0.78. The medical equipment provider earned $806.10 million during the quarter, compared to analysts' expectations of $753.25 million. Intuitive Surgical had a net margin of 36.91% and a return on equity of 25.17%. The firm's revenue for the quarter was up 18.0% compared to the same quarter last year. During the same period last year, the business posted $2.06 earnings per share. View Intuitive Surgical's Earnings History.

When will Intuitive Surgical make its next earnings announcement?

Intuitive Surgical is scheduled to release their next quarterly earnings announcement on Monday, January, 22nd 2018. View Earnings Estimates for Intuitive Surgical.

Where is Intuitive Surgical's stock going? Where will Intuitive Surgical's stock price be in 2017?

16 brokers have issued 12-month price objectives for Intuitive Surgical's stock. Their forecasts range from $75.00 to $353.33. On average, they expect Intuitive Surgical's share price to reach $139.91 in the next year. View Analyst Ratings for Intuitive Surgical.

What are Wall Street analysts saying about Intuitive Surgical stock?

Here are some recent quotes from research analysts about Intuitive Surgical stock:

  • 1. According to Zacks Investment Research, "Over the last three months, Intuitive Surgical has been consistently trading above the broader industry. Its third quarter earnings and revenues both topped the Zacks Consensus Estimate. The company’s procedure performance in Asia showed continued strength with solid growth in China, Japan and Korea. Intuitive Surgical gained significantly on the CE Mark approval for da Vinci X in Europe. The stock received further boost on the recent FDA approval of the same. Also, a solid outlook for the coming quarters also raises our confidence in the stock. Further, incremental spending on product development and higher investments in international markets are prudent moves that are likely to drive long-term growth. The company is also expected to enhance its organizational capabilities and gain prominence in the markets of Europe and Asia." (11/14/2017)
  • 2. Cantor Fitzgerald analysts commented, "Procedure growth: Guidance for 2017 procedure growth appears to be conservative. ISRG had 17% procedure growth in the 1H and is guiding to 14-15% procedure growth for 2017, implying 11-13% procedure growth in the 2H. The first-half procedure growth came in above expectations, as gynecology (grew in low single digits) and urology (grew in mid-to-high single digits) and China (grew by well over 25%) outpaced expectations. Second-half guidance assumes slower growth in gynecology, urology, and China, one less selling day in 3Q, and lower growth in Japan due to a lack of reimbursement." (7/21/2017)
  • 3. Canaccord Genuity analysts commented, "Our checks at the SAGES conference in Houston this week reaffirmed our near-term bullishness about the firm's fundamentals. A year ago coming out of this important trade show, we opined that a robotics revolution was underway in general surgery;our checks at SAGES 2017 suggest the revolution continues ' especially in hernia repair. Given the large opportunity open to robotic surgery ' nearly 1M annual hernia procedures in the U.S. of which nearly 70% are currently performed via an invasive, open surgery ' we discerned escalating enthusiasm from robotic surgeons. In sum, we think ISRG is positioned well to deliver procedure volume growth at or above its current guidance, which calls for 9-12% growth in 2017. On the competitive front, Medtronic looks to be at least a few years out, but seems to be ISRG's most imminent challenger. At an analyst meeting during SAGES yesterday, Medtronic updated its projections for entry into the surgical robotics arena, targeting initial market entry into a few small countries in Europe before the end of F2018 (April '18). Further, Medtronic expects FDA approval, as well as market expansion into larger European markets, during its F2019, with material revenue contributions expected over that timeframe. Meanwhile, we think ISRG (the company and the stock) still has room to run. We maintain our BUY rating and $800 price target." (3/24/2017)

Who are some of Intuitive Surgical's key competitors?

Who are Intuitive Surgical's key executives?

Intuitive Surgical's management team includes the folowing people:

  • Lonnie M. Smith, Independent Chairman of the Board
  • Gary S. Guthart Ph.D., President, Chief Executive Officer, Director
  • Marshall L. Mohr, Chief Financial Officer, Senior Vice President
  • Salvatore J. Brogna, Chief Operating Officer, Executive Vice President
  • David J. Rosa, Executive Vice President, Chief Commercial Officer
  • Mark J. Meltzer, Senior Vice President, Chief Compliance Officer, General Counsel
  • Myriam J. Curet M.D., Senior Vice President, Chief Medical Officer
  • Jamie E. Samath, Vice President, Corporate Controller, and Principal Accounting Officer
  • Alan J. Levy Ph.D., Lead Independent Director
  • Craig H. Barratt Ph.D., Independent Director

Who owns Intuitive Surgical stock?

Intuitive Surgical's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Edgewood Management LLC (2.59%), Bank of New York Mellon Corp (1.21%), Baillie Gifford & Co. (1.01%), Janus Henderson Group PLC (0.52%), American Century Companies Inc. (0.49%) and Brown Advisory Inc. (0.44%). Company insiders that own Intuitive Surgical stock include Alan J Levy, Amal M Johnson, Colin Morales, Craig H Barratt, Curet Myriam, David J Rosa, Eric H Halvorson, Gary S Guthart, George Stalk Jr, Jamie Samath, Keith R Leonard, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr, Michael A Friedman and Salvatore Brogna. View Institutional Ownership Trends for Intuitive Surgical.

Who sold Intuitive Surgical stock? Who is selling Intuitive Surgical stock?

Intuitive Surgical's stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Brown Advisory Inc., Wells Fargo & Company MN, Baillie Gifford & Co., Old Mutual Global Investors UK Ltd., Nomura Asset Management Co. Ltd., Bluestein R H & Co. and American Century Companies Inc.. Company insiders that have sold Intuitive Surgical company stock in the last year include Alan J Levy, Amal M Johnson, Colin Morales, Craig H Barratt, Curet Myriam, David J Rosa, Gary S Guthart, Jamie Samath, Keith R Leonard, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr, Michael A Friedman and Salvatore Brogna. View Insider Buying and Selling for Intuitive Surgical.

Who bought Intuitive Surgical stock? Who is buying Intuitive Surgical stock?

Intuitive Surgical's stock was purchased by a variety of institutional investors in the last quarter, including Edgewood Management LLC, Janus Henderson Group PLC, APG Asset Management N.V., Biondo Investment Advisors LLC, Aperio Group LLC, Global X MANAGEMENT CO LLC, Robeco Institutional Asset Management B.V. and Bender Robert & Associates. View Insider Buying and Selling for Intuitive Surgical.

How do I buy Intuitive Surgical stock?

Shares of Intuitive Surgical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Intuitive Surgical's stock price today?

One share of Intuitive Surgical stock can currently be purchased for approximately $396.59.

How big of a company is Intuitive Surgical?

Intuitive Surgical has a market capitalization of $44.65 billion and generates $2.70 billion in revenue each year. The medical equipment provider earns $735.90 million in net income (profit) each year or $7.74 on an earnings per share basis. Intuitive Surgical employs 3,755 workers across the globe.

How can I contact Intuitive Surgical?

Intuitive Surgical's mailing address is 1020 KIFER ROAD, SUNNYVALE CA, 94086. The medical equipment provider can be reached via phone at 408-523-2100 or via email at [email protected]


MarketBeat Community Rating for Intuitive Surgical (ISRG)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  537 (Vote Outperform)
Underperform Votes:  443 (Vote Underperform)
Total Votes:  980
MarketBeat's community ratings are surveys of what our community members think about Intuitive Surgical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Intuitive Surgical (NASDAQ:ISRG)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 5 Hold Ratings, 11 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.69)
Consensus Price Target: $139.91 (64.72% downside)

Consensus Price Target History for Intuitive Surgical (NASDAQ:ISRG)

Price Target History for Intuitive Surgical (NASDAQ:ISRG)

Analysts' Ratings History for Intuitive Surgical (NASDAQ:ISRG)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/18/2017Goldman Sachs Group, Inc. (The)Reiterated RatingBuyN/AView Rating Details
10/20/2017Barclays PLCReiterated RatingOverweightN/AView Rating Details
10/17/2017Canaccord GenuityReiterated RatingHoldN/AView Rating Details
10/16/2017Wells Fargo & CoReiterated RatingBuyN/AView Rating Details
10/10/2017WedbushReiterated RatingBuyN/AView Rating Details
9/5/2017Morgan StanleyReiterated RatingOverweightHighView Rating Details
9/1/2017Royal Bank Of CanadaReiterated RatingHold$333.33N/AView Rating Details
7/24/2017Citigroup Inc.Reiterated RatingBuy$101.89 -> $119.78LowView Rating Details
7/22/2017Stifel NicolausReiterated RatingBuy$94.44 -> $122.22MediumView Rating Details
7/21/2017J P Morgan Chase & CoReiterated RatingOverweight$116.67HighView Rating Details
7/21/2017Cantor FitzgeraldReiterated RatingHold$116.67HighView Rating Details
7/5/2017Leerink SwannReiterated RatingOutperformMediumView Rating Details
6/15/2017BTIG ResearchReiterated RatingHoldLowView Rating Details
6/1/2017Bank of America CorporationReiterated RatingBuy$111.11LowView Rating Details
4/25/2017Jefferies Group LLCReiterated RatingBuy$75.00LowView Rating Details
4/19/2017Evercore ISIBoost Price TargetIn-Line$83.33 -> $87.22LowView Rating Details
8/26/2016Raymond James Financial, Inc.Initiated CoverageOutperformN/AView Rating Details
7/21/2016Northland SecuritiesDowngradeMarket Perform -> Under Perform$66.67N/AView Rating Details
7/20/2016Piper Jaffray CompaniesReiterated RatingNeutral$67.78 -> $77.78N/AView Rating Details
4/14/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
1/22/2016William BlairReiterated RatingBuyN/AView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for Intuitive Surgical (NASDAQ:ISRG)

Earnings by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Earnings History by Quarter for Intuitive Surgical (NASDAQ ISRG)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/22/2018$2.26N/AView Earnings Details
10/19/2017Q3 2017$1.99$2.77$753.25 million$806.10 millionViewN/AView Earnings Details
7/20/2017Q2 2017$0.64$0.66$724.51 million$756.20 millionViewN/AView Earnings Details
4/18/2017Q1 17$0.44$0.57$664.72 million$674.20 millionViewN/AView Earnings Details
1/24/2017Q416$0.67$0.68$739.65 million$757.00 millionViewN/AView Earnings Details
10/18/2016Q3$0.57$0.69$650.49 million$682.90 millionViewListenView Earnings Details
7/19/2016Q216$0.55$0.62$640.69 million$670.00 millionViewListenView Earnings Details
4/19/2016Q1$0.48$0.49$593.08 million$594.50 millionViewListenView Earnings Details
1/21/2016Q4$0.56$0.65$655.32 million$676.50 millionViewListenView Earnings Details
10/20/2015Q3$0.47$0.58$580.37 million$590.00 millionViewListenView Earnings Details
7/21/2015Q2$0.44$0.51$566.86 million$586.10 millionViewListenView Earnings Details
4/21/2015Q1$0.32$0.40$535.10 million$532.10 millionViewListenView Earnings Details
1/22/2015Q4$0.38$0.46$599.17 million$604.70 millionViewListenView Earnings Details
10/21/2014Q314$0.30$0.44$515.44 million$550.00 millionViewListenView Earnings Details
7/22/2014Q214$0.31$0.31$502.23 million$512.00 millionViewListenView Earnings Details
4/22/2014Q114$0.37$0.30$507.04 million$464.70 millionViewListenView Earnings Details
1/23/2014Q413$0.42$0.48$576.00 million$576.20 millionViewListenView Earnings Details
10/17/2013Q313$0.38$0.44$525.47 million$499.00 millionViewListenView Earnings Details
7/18/2013Q2 2013$0.45$0.43$594.58 million$578.50 millionViewListenView Earnings Details
4/18/2013Q1 2013$0.45$0.51$583.59 million$611.40 millionViewListenView Earnings Details
1/22/2013Q4 2012$0.45$0.47$584.36 million$609.30 millionViewListenView Earnings Details
10/16/2012$0.39$0.50ViewN/AView Earnings Details
7/19/2012$0.40$0.42ViewN/AView Earnings Details
4/17/2012$0.35$0.39ViewN/AView Earnings Details
1/19/2012$0.37$0.42ViewN/AView Earnings Details
10/18/2011$0.31$0.34ViewN/AView Earnings Details
7/19/2011$0.30$0.32ViewN/AView Earnings Details
4/19/2011$0.28$0.29ViewN/AView Earnings Details
1/20/2011$0.25$0.34ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intuitive Surgical (NASDAQ:ISRG)
2017 EPS Consensus Estimate: $15.35
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$3.96$3.96$3.96
Q2 20171$4.55$4.55$4.55
Q3 20171$4.89$4.89$4.89
Q4 20171$1.95$1.95$1.95
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intuitive Surgical (NASDAQ:ISRG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Intuitive Surgical (NASDAQ ISRG)

Insider Ownership Percentage: 2.20%
Institutional Ownership Percentage: 32.95%
Insider Trades by Quarter for Intuitive Surgical (NASDAQ:ISRG)
Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Insider Trades by Quarter for Intuitive Surgical (NASDAQ ISRG)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/21/2017Mark J MeltzerSVPSell6,000$397.14$2,382,840.00View SEC Filing  
11/10/2017Lonnie M SmithDirectorSell580$386.76$224,320.80View SEC Filing  
10/30/2017Marshall MohrCFOSell6,000$372.22$2,233,320.00View SEC Filing  
10/26/2017Craig H BarrattInsiderSell7,500$381.00$2,857,500.00View SEC Filing  
10/24/2017Alan J. LevyDirectorSell2,997$371.35$1,112,935.95View SEC Filing  
10/24/2017Craig H BarrattInsiderSell15,000$371.18$5,567,700.00View SEC Filing  
10/24/2017Curet MyriamSVPSell262$373.00$97,726.00View SEC Filing  
10/24/2017Jamie SamathVPSell1,564$371.19$580,541.16View SEC Filing  
9/5/2017Mark J MeltzerSVPSell500$1,025.00$512,500.00View SEC Filing  
9/1/2017Salvatore BrognaEVPSell899$1,001.90$900,708.10View SEC Filing  
8/31/2017Keith R LeonardDirectorSell854$1,000.00$854,000.00View SEC Filing  
8/22/2017Mark J MeltzerSVPSell500$982.90$491,450.00View SEC Filing  
7/27/2017Gary S GuthartCEOSell17,975$937.27$16,847,428.25View SEC Filing  
7/25/2017Curet MyriamSVPSell1,202$950.20$1,142,140.40View SEC Filing  
7/25/2017Jamie SamathVPSell242$949.01$229,660.42View SEC Filing  
7/25/2017Michael A FriedmanDirectorSell1,000$945.60$945,600.00View SEC Filing  
6/12/2017Mark J MeltzerSVPSell3,000$887.09$2,661,270.00View SEC Filing  
6/8/2017Mark J RubashDirectorSell3,000$931.51$2,794,530.00View SEC Filing  
6/7/2017Curet MyriamSVPSell750$930.00$697,500.00View SEC Filing  
6/5/2017Curet MyriamSVPSell2,644$921.26$2,435,811.44View SEC Filing  
6/5/2017Jamie SamathVPSell1,946$921.26$1,792,771.96View SEC Filing  
6/1/2017Salvatore BrognaEVPSell1,306$915.09$1,195,107.54View SEC Filing  
5/31/2017Amal M JohnsonDirectorSell1,000$917.27$917,270.00View SEC Filing  
5/5/2017Jamie SamathVPSell48$850.00$40,800.00View SEC Filing  
5/2/2017Curet MyriamSVPSell3,385$837.21$2,833,955.85View SEC Filing  
4/27/2017Marshall MohrCFOSell8,950$835.89$7,481,215.50View SEC Filing  
4/25/2017Jamie SamathVPSell626$825.00$516,450.00View SEC Filing  
4/24/2017Alan J LevyDirectorSell1,386$813.15$1,127,025.90View SEC Filing  
4/21/2017David J. RosaEVPSell5,000$810.52$4,052,600.00View SEC Filing  
4/21/2017Gary S GuthartCEOSell18,775$810.33$15,213,945.75View SEC Filing  
4/21/2017Jamie SamathVPSell490$811.67$397,718.30View SEC Filing  
4/21/2017Lonnie M SmithDirectorSell3,000$810.12$2,430,360.00View SEC Filing  
3/15/2017Amal M JohnsonDirectorSell1,000$750.00$750,000.00View SEC Filing  
3/15/2017David J RosaEVPSell5,000$750.00$3,750,000.00View SEC Filing  
3/15/2017Jamie SamathVPSell4,268$750.00$3,201,000.00View SEC Filing  
3/15/2017Marshall MohrCFOSell4,250$750.00$3,187,500.00View SEC Filing  
3/1/2017Salvatore BrognaEVPSell6,628$736.80$4,883,510.40View SEC Filing  
2/24/2017Curet MyriamSVPSell222$729.80$162,015.60View SEC Filing  
2/21/2017Mark J MeltzerSVPSell8,750$724.82$6,342,175.00View SEC Filing  
2/7/2017Colin MoralesSVPSell1,000$703.99$703,990.00View SEC Filing  
2/2/2017Marshall MohrCFOSell2,000$700.00$1,400,000.00View SEC Filing  
1/27/2017Lonnie M SmithDirectorSell1,000$684.38$684,380.00View SEC Filing  
12/13/2016David J RosaEVPSell7,200$650.00$4,680,000.00View SEC Filing  
12/13/2016Lonnie M SmithDirectorSell1,000$650.00$650,000.00View SEC Filing  
11/17/2016Lonnie M SmithDirectorSell275$646.50$177,787.50View SEC Filing  
11/7/2016Gary S GuthartCEOSell13,515$680.68$9,199,390.20View SEC Filing  
8/22/2016Mark J MeltzerSVPSell3,000$688.33$2,064,990.00View SEC Filing  
8/4/2016Alan J LevyDirectorSell3,188$694.11$2,212,822.68View SEC Filing  
8/1/2016Gary S GuthartCEOSell13,400$698.00$9,353,200.00View SEC Filing  
7/27/2016Curet MyriamSVPSell4,250$684.39$2,908,657.50View SEC Filing  
7/27/2016Marshall MohrCFOSell5,000$684.09$3,420,450.00View SEC Filing  
6/2/2016Salvatore BrognaEVPSell600$630.96$378,576.00View SEC Filing  
6/1/2016Salvatore BrognaEVPSell20,406$632.66$12,910,059.96View SEC Filing  
5/17/2016Curet MyriamSVPSell530$629.36$333,560.80View SEC Filing  
5/17/2016Lonnie M SmithDirectorSell2,000$627.23$1,254,460.00View SEC Filing  
5/3/2016George Stalk JrDirectorSell7,644$618.70$4,729,342.80View SEC Filing  
5/2/2016Marshall MohrCFOSell5,000$631.63$3,158,150.00View SEC Filing  
4/27/2016Mark J MeltzerSVPSell16,625$631.52$10,499,020.00View SEC Filing  
4/26/2016Alan J LevyDirectorSell542$631.72$342,392.24View SEC Filing  
4/25/2016Amal M JohnsonDirectorSell2,500$640.00$1,600,000.00View SEC Filing  
4/22/2016Curet MyriamSVPSell8,173$637.75$5,212,330.75View SEC Filing  
4/22/2016Eric H HalvorsonDirectorSell5,688$639.21$3,635,826.48View SEC Filing  
3/14/2016Eric H HalvorsonDirectorSell4,438$593.16$2,632,444.08View SEC Filing  
3/14/2016Mark J MeltzerSVPSell12,500$589.00$7,362,500.00View SEC Filing  
3/11/2016Curet MyriamSVPSell2,000$582.50$1,165,000.00View SEC Filing  
3/11/2016Jamie SamathVPSell8,026$575.95$4,622,574.70View SEC Filing  
3/10/2016Alan J LevyDirectorSell5,000$569.14$2,845,700.00View SEC Filing  
3/7/2016Colin MoralesSVPSell2,500$575.00$1,437,500.00View SEC Filing  
3/4/2016Colin MoralesSVPSell884$571.49$505,197.16View SEC Filing  
3/3/2016Marshall MohrCFOSell2,500$575.00$1,437,500.00View SEC Filing  
3/2/2016Salvatore BrognaEVPSell1,882$567.37$1,067,790.34View SEC Filing  
2/19/2016Colin MoralesSVPSell5,530$542.83$3,001,849.90View SEC Filing  
2/4/2016Curet MyriamSVPSell2,000$551.00$1,102,000.00View SEC Filing  
2/4/2016Marshall MohrCFOSell2,500$550.00$1,375,000.00View SEC Filing  
1/29/2016Mark J. MeltzerSVPSell4,125$527.59$2,176,308.75View SEC Filing  
12/14/2015Salvatore BrognaEVPSell2,734$530.00$1,449,020.00View SEC Filing  
11/20/2015Mark J. MeltzerSVPSell1,625$515.00$836,875.00View SEC Filing  
10/26/2015Mark J. MeltzerSVPSell2,500$498.37$1,245,925.00View SEC Filing  
10/23/2015Lonnie M. SmithDirectorSell10,328$500.00$5,164,000.00View SEC Filing  
9/1/2015Salvatore BrognaEVPSell374$501.99$187,744.26View SEC Filing  
8/18/2015George Stalk JrDirectorSell4,726$532.03$2,514,373.78View SEC Filing  
7/27/2015Gary S GuthartCEOSell17,255$541.98$9,351,864.90View SEC Filing  
7/27/2015Mark J MeltzerSVPSell4,750$542.03$2,574,642.50View SEC Filing  
7/24/2015David J RosaEVPSell2,800$550.20$1,540,560.00View SEC Filing  
7/24/2015Jamie SamathVPSell5,000$550.00$2,750,000.00View SEC Filing  
7/24/2015Lonnie M SmithDirectorSell20,000$544.62$10,892,400.00View SEC Filing  
6/9/2015Alan J LevyDirectorSell417$495.41$206,585.97View SEC Filing  
6/8/2015Gary S GuthartCEOSell17,840$492.16$8,780,134.40View SEC Filing  
5/29/2015Lonnie M SmithDirectorSell2,000$488.68$977,360.00View SEC Filing  
5/27/2015Curet MyriamSVPSell1,000$489.35$489,350.00View SEC Filing  
5/18/2015Colin MoralesSVPSell13,824$503.29$6,957,480.96View SEC Filing  
4/28/2015Curet MyriamSVPSell261$504.54$131,684.94View SEC Filing  
4/27/2015Jerome J McnamaraEVPSell15,000$504.06$7,560,900.00View SEC Filing  
4/27/2015Marshall MohrCFOSell10,000$504.08$5,040,800.00View SEC Filing  
4/24/2015Lonnie M SmithDirectorSell20,000$508.03$10,160,600.00View SEC Filing  
3/2/2015Salvatore BrognaSVPSell1,375$500.98$688,847.50View SEC Filing  
2/6/2015Mark J RubashDirectorSell5,000$520.00$2,600,000.00View SEC Filing  
1/27/2015Jerome J McnamaraEVPSell15,000$511.32$7,669,800.00View SEC Filing  
1/27/2015Lonnie M SmithDirectorSell20,000$511.31$10,226,200.00View SEC Filing  
1/27/2015Marshall MohrCFOSell5,000$511.14$2,555,700.00View SEC Filing  
12/8/2014Lonnie M SmithDirectorSell1,700$511.24$869,108.00View SEC Filing  
12/1/2014Salvatore BrognaSVPSell1,375$515.87$709,321.25View SEC Filing  
11/24/2014Colin MoralesSVPSell9,565$520.82$4,981,643.30View SEC Filing  
10/31/2014Marshall MohrCFOSell7,500$500.00$3,750,000.00View SEC Filing  
10/30/2014Floyd D Md LoopDirectorSell2,125$488.95$1,039,018.75View SEC Filing  
10/27/2014Floyd D Md LoopDirectorSell15,209$475.71$7,235,073.39View SEC Filing  
10/27/2014Jerome J McnamaraEVPSell15,000$473.76$7,106,400.00View SEC Filing  
10/27/2014Marshall MohrCFOSell2,500$473.50$1,183,750.00View SEC Filing  
9/2/2014Salvatore BrognaSVPSell12,626$472.06$5,960,229.56View SEC Filing  
8/26/2014Colin MoralesSVPSell4,105$478.66$1,964,899.30View SEC Filing  
7/28/2014Jerome J McnamaraEVPSell9,167$465.59$4,268,063.53View SEC Filing  
7/25/2014Colin MoralesSVPSell2,000$461.99$923,980.00View SEC Filing  
2/27/2014Colin MoralesSVPSell1,000$445.00$445,000.00View SEC Filing  
12/3/2012Lonnie M SmithChairmanSell1,000$525.98$525,980.00View SEC Filing  
9/4/2012Salvatore BrognaSVPSell1,250$490.25$612,812.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Intuitive Surgical (NASDAQ ISRG)

Source:
DateHeadline
Edited Transcript of ISRG earnings conference call or presentation 24-Jan-17 9:30pm GMTEdited Transcript of ISRG earnings conference call or presentation 24-Jan-17 9:30pm GMT
finance.yahoo.com - November 23 at 2:31 AM
Intuitive Surgical, Inc. (ISRG) Expected to Announce Earnings of $2.25 Per ShareIntuitive Surgical, Inc. (ISRG) Expected to Announce Earnings of $2.25 Per Share
www.americanbankingnews.com - November 22 at 9:34 PM
Mark J. Meltzer Sells 6,000 Shares of Intuitive Surgical, Inc. (ISRG) StockMark J. Meltzer Sells 6,000 Shares of Intuitive Surgical, Inc. (ISRG) Stock
www.americanbankingnews.com - November 22 at 1:38 PM
Intuitive Surgical Hits a 52-Week High on Solid Prospects - NasdaqIntuitive Surgical Hits a 52-Week High on Solid Prospects - Nasdaq
www.nasdaq.com - November 21 at 8:12 PM
Cramer Remix: Forget the $450M painting, Intuitive Surgical is the da Vinci of stocks - CNBCCramer Remix: Forget the $450M painting, Intuitive Surgical is the da Vinci of stocks - CNBC
www.cnbc.com - November 21 at 8:12 PM
Why Is Intuitive Surgical (ISRG) Up 9.8% Since the Last Earnings ... - NasdaqWhy Is Intuitive Surgical (ISRG) Up 9.8% Since the Last Earnings ... - Nasdaq
www.nasdaq.com - November 21 at 8:12 PM
Technical Analysis Explains Intuitive Surgicals Huge UptrendTechnical Analysis Explains Intuitive Surgical's Huge Uptrend
finance.yahoo.com - November 21 at 8:12 PM
Cramer: You Mean to Tell Me Bitcoin Is Not a Bubble?Cramer: You Mean to Tell Me Bitcoin Is Not a Bubble?
finance.yahoo.com - November 21 at 8:12 PM
Top-End Metrics for Earnings Visibility Keep Intuitive Surgical (ISRG) a Strong BuyTop-End Metrics for Earnings Visibility Keep Intuitive Surgical (ISRG) a Strong Buy
investorplace.com - November 21 at 11:08 AM
Cramer Remix: Forget the $450M painting, Intuitive Surgical is the da Vinci of stocksCramer Remix: Forget the $450M painting, Intuitive Surgical is the da Vinci of stocks
finance.yahoo.com - November 20 at 9:54 PM
Breakfast Technical Briefing on Medical Equipment Stocks -- Intuitive Surgical, AcelRx Pharma, GenMark Diagnostics, and LantheusBreakfast Technical Briefing on Medical Equipment Stocks -- Intuitive Surgical, AcelRx Pharma, GenMark Diagnostics, and Lantheus
www.bizjournals.com - November 20 at 4:51 PM
Intuitive Surgical Hits a 52-Week High on Solid ProspectsIntuitive Surgical Hits a 52-Week High on Solid Prospects
finance.yahoo.com - November 20 at 4:50 PM
Intuitive Surgical, Inc. (ISRG) Receives Average Recommendation of "Buy" from BrokeragesIntuitive Surgical, Inc. (ISRG) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - November 20 at 4:04 PM
Why Is Intuitive Surgical (ISRG) Up 9.8% Since the Last Earnings Report?Why Is Intuitive Surgical (ISRG) Up 9.8% Since the Last Earnings Report?
finance.yahoo.com - November 20 at 5:08 AM
Intuitive Surgicals (ISRG) Buy Rating Reaffirmed at Goldman Sachs Group, Inc. (The)Intuitive Surgical's (ISRG) Buy Rating Reaffirmed at Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - November 19 at 7:56 AM
Are Options Traders Betting on a Big Move in Intuitive Surgical (ISRG) Stock?Are Options Traders Betting on a Big Move in Intuitive Surgical (ISRG) Stock?
finance.yahoo.com - November 18 at 7:05 PM
Five Lesser-Known Rule Breakers: A Two-Year ReviewFive Lesser-Known Rule Breakers: A Two-Year Review
finance.yahoo.com - November 18 at 7:05 PM
Are Options Traders Betting on a Big Move in Intuitive Surgical (ISRG) Stock? - NasdaqAre Options Traders Betting on a Big Move in Intuitive Surgical (ISRG) Stock? - Nasdaq
www.nasdaq.com - November 17 at 8:19 AM
Intuitive Surgical (ISRG) to Gain From Procedural Business - NasdaqIntuitive Surgical (ISRG) to Gain From Procedural Business - Nasdaq
www.nasdaq.com - November 17 at 8:19 AM
Buy red-hot robot maker Intuitive Surgical, Goldman saysBuy red-hot robot maker Intuitive Surgical, Goldman says
www.cnbc.com - November 16 at 3:28 PM
Is Intuitive Surgical, Inc. a Buy?Is Intuitive Surgical, Inc. a Buy?
www.fool.com - November 15 at 9:22 PM
Intuitive Surgical (ISRG) a Strong Buy on Top-End Sales Growth - Investorplace.comIntuitive Surgical (ISRG) a Strong Buy on Top-End Sales Growth - Investorplace.com
investorplace.com - November 15 at 3:21 AM
Intuitive Surgical, Inc. (ISRG) Director Sells $224,320.80 in StockIntuitive Surgical, Inc. (ISRG) Director Sells $224,320.80 in Stock
www.americanbankingnews.com - November 14 at 4:34 PM
Intuitive Surgical (ISRG) a Strong Buy on Top-End Sales GrowthIntuitive Surgical (ISRG) a Strong Buy on Top-End Sales Growth
investorplace.com - November 14 at 11:13 AM
Intuitive Surgicals Stock Rally Mostly Justified, But May Be OverdoneIntuitive Surgical's Stock Rally Mostly Justified, But May Be Overdone
finance.yahoo.com - November 13 at 4:23 PM
Intuitive Surgical, Inc. (ISRG) Downgraded by Zacks Investment Research to "Hold"Intuitive Surgical, Inc. (ISRG) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - November 13 at 12:41 PM
ETFs with exposure to Intuitive Surgical, Inc. : November 9, 2017ETFs with exposure to Intuitive Surgical, Inc. : November 9, 2017
finance.yahoo.com - November 11 at 6:28 PM
Dull MFA & Mineral Nutrition Sales Hurt Phirbo, Rivalry RifeDull MFA & Mineral Nutrition Sales Hurt Phirbo, Rivalry Rife
finance.yahoo.com - November 11 at 6:28 PM
TransEnterix (TRXC) Posts In-Line Loss in Q3, Sales Fall Y/YTransEnterix (TRXC) Posts In-Line Loss in Q3, Sales Fall Y/Y
finance.yahoo.com - November 11 at 6:28 PM
QIAGEN (QGEN) Faces Declining HPV Sales, Intense CompetitionQIAGEN (QGEN) Faces Declining HPV Sales, Intense Competition
finance.yahoo.com - November 11 at 6:28 PM
Brukers NANO Grows Strong, MERLIN Buyout Holds Promise - NasdaqBruker's NANO Grows Strong, MERLIN Buyout Holds Promise - Nasdaq
www.nasdaq.com - November 11 at 1:26 PM
VWR Q3 Earnings Top, Sell-Off to Avantor Approaching Closure - NasdaqVWR Q3 Earnings Top, Sell-Off to Avantor Approaching Closure - Nasdaq
www.nasdaq.com - November 8 at 10:37 AM
Outstanding Earnings Momentum Keeps Intuitive Surgical (ISRG) a Strong Buy - Investorplace.comOutstanding Earnings Momentum Keeps Intuitive Surgical (ISRG) a Strong Buy - Investorplace.com
investorplace.com - November 8 at 10:37 AM
Outstanding Earnings Momentum Keeps Intuitive Surgical (ISRG) a Strong BuyOutstanding Earnings Momentum Keeps Intuitive Surgical (ISRG) a Strong Buy
investorplace.com - November 7 at 2:42 PM
Materion Corporation (MTRN) Ex-Dividend Date Scheduled for NovemberMaterion Corporation (MTRN) Ex-Dividend Date Scheduled for November
www.nasdaq.com - November 7 at 4:59 AM
Intuitive Surgical (ISRG) & Its Peers Critical AnalysisIntuitive Surgical (ISRG) & Its Peers Critical Analysis
www.americanbankingnews.com - November 6 at 1:33 PM
This Growing Robotics Company Is a Hit With Surgeons (Hint: Its not Intuitive Surgical)This Growing Robotics Company Is a Hit With Surgeons (Hint: It's not Intuitive Surgical)
www.fool.com - November 5 at 7:19 PM
$845.66 Million in Sales Expected for Intuitive Surgical, Inc. (ISRG) This Quarter$845.66 Million in Sales Expected for Intuitive Surgical, Inc. (ISRG) This Quarter
www.americanbankingnews.com - November 5 at 4:32 AM
DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q3 - NasdaqDENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q3 - Nasdaq
www.nasdaq.com - November 4 at 2:50 AM
New Study Reports Favorable Results for Intuitive Surgicals Flexible ... - GlobeNewswire (press release)New Study Reports Favorable Results for Intuitive Surgical's Flexible ... - GlobeNewswire (press release)
globenewswire.com - November 3 at 10:34 AM
DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q3DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q3
finance.yahoo.com - November 3 at 10:34 AM
Head-To-Head Contrast: Intuitive Surgical (ISRG) and Its CompetitorsHead-To-Head Contrast: Intuitive Surgical (ISRG) and Its Competitors
www.americanbankingnews.com - November 3 at 5:32 AM
How Intuitive Surgical Reported Such High Margins in 3Q17How Intuitive Surgical Reported Such High Margins in 3Q17
finance.yahoo.com - November 2 at 2:55 AM
Why Intuitive Surgical Is Focusing on Imaging, Instruments, and Accessory SalesWhy Intuitive Surgical Is Focusing on Imaging, Instruments, and Accessory Sales
finance.yahoo.com - November 2 at 2:55 AM
Masimo (MASI) Beats on Q3 Earnings and Revenues, Raises ViewMasimo (MASI) Beats on Q3 Earnings and Revenues, Raises View
finance.yahoo.com - November 2 at 2:55 AM
Behind Intuitive Surgical’s Updated Fiscal 2017 GuidanceBehind Intuitive Surgical’s Updated Fiscal 2017 Guidance
finance.yahoo.com - November 2 at 2:55 AM
Zimmer Biomet's (ZBH) Q3 Earnings Lag Estimates, View DownZimmer Biomet's (ZBH) Q3 Earnings Lag Estimates, View Down
finance.yahoo.com - November 2 at 2:55 AM
Robot-Assisted Surgery Costs More But May Not Be BetterRobot-Assisted Surgery Costs More But May Not Be Better
finance.yahoo.com - November 1 at 12:05 AM
Behind Intuitive Surgical’s Key Revenue Growth Drivers in 3Q17Behind Intuitive Surgical’s Key Revenue Growth Drivers in 3Q17
finance.yahoo.com - November 1 at 12:05 AM
Behind Intuitive Surgical’s Procedure Momentum in 3Q17Behind Intuitive Surgical’s Procedure Momentum in 3Q17
finance.yahoo.com - November 1 at 12:05 AM

Social Media

Financials

Chart

Intuitive Surgical (NASDAQ ISRG) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.